Form 4: MEI Pharma Director Steven D. Wood Reports Stock Transactions
SEC Form 4 Filing
Director Steven D. Wood reports purchasing shares of MEI Pharma and indirectly disposing of shares.
Summary
- On May 17, 2024, Steven D. Wood, a director of MEI Pharma, Inc., acquired 3,100 shares of common stock at a weighted-average price of $3.1701 per share.
- The prices for these shares ranged from $3.10 to $3.18.
- Wood also indirectly disposed of 4,359 shares.
- Following these transactions, Wood directly owns 4,359 shares and indirectly owns 67,733 shares through GreenWood Builders Fund III, LP.
- Wood disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with neutral sentiment.
Management Comments
- Mr. Wood disclaims such beneficial ownership except to the extent of his pecuniary interest therein, if any.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is common in the pharmaceutical industry.
Stakeholder Impact
- The stock transactions may have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/17/2024 | Date of stock purchase and disposal transactions |
| 05/21/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.